217 related articles for article (PubMed ID: 22418442)
21. Effect of verocytotoxins (Shiga-like toxins) on human neutrophils in vitro.
Holle JU; Williams JM; Harper L; Savage CO; Taylor CM
Pediatr Nephrol; 2005 Sep; 20(9):1237-44. PubMed ID: 15947986
[TBL] [Abstract][Full Text] [Related]
22. Generation of receptor-active, globotriaosyl ceramide/cholesterol lipid 'rafts' in vitro : A new assay to define factors affecting glycosphingolipid receptor activity.
Nutikka A; Lingwood C
Glycoconj J; 2004; 20(1):33-8. PubMed ID: 14973368
[TBL] [Abstract][Full Text] [Related]
23. Essential role for verotoxin in sustained stress-activated protein kinase and nuclear factor kappa B signaling, stimulated by Escherichia coli O157:H7 in Vero cells.
Cameron P; Bingham D; Paul A; Pavelka M; Cameron S; Rotondo D; Plevin R
Infect Immun; 2002 Oct; 70(10):5370-80. PubMed ID: 12228261
[TBL] [Abstract][Full Text] [Related]
24. Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits.
Bielaszewska M; Clarke I; Karmali MA; Petric M
Infect Immun; 1997 Jul; 65(7):2509-16. PubMed ID: 9199412
[TBL] [Abstract][Full Text] [Related]
25. The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect.
Smith DC; Sillence DJ; Falguières T; Jarvis RM; Johannes L; Lord JM; Platt FM; Roberts LM
Mol Biol Cell; 2006 Mar; 17(3):1375-87. PubMed ID: 16381816
[TBL] [Abstract][Full Text] [Related]
26. Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits.
Bast DJ; Brunton JL; Karmali MA; Richardson SE
Infect Immun; 1997 Jun; 65(6):2019-28. PubMed ID: 9169727
[TBL] [Abstract][Full Text] [Related]
27. Adamantyl glycosphingolipids provide a new approach to the selective regulation of cellular glycosphingolipid metabolism.
Kamani M; Mylvaganam M; Tian R; Rigat B; Binnington B; Lingwood C
J Biol Chem; 2011 Jun; 286(24):21413-26. PubMed ID: 21518770
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a microplate latex agglutination method (Verotox-F assay) for detecting and characterizing verotoxins (Shiga toxins) in Escherichia coli.
Karmali MA; Petric M; Bielaszewska M
J Clin Microbiol; 1999 Feb; 37(2):396-9. PubMed ID: 9889226
[TBL] [Abstract][Full Text] [Related]
29. Adamantyl globotriaosyl ceramide: a monovalent soluble mimic which inhibits verotoxin binding to its glycolipid receptor.
Mylvaganam M; Lingwood CA
Biochem Biophys Res Commun; 1999 Apr; 257(2):391-4. PubMed ID: 10198223
[TBL] [Abstract][Full Text] [Related]
30. The identification of three biologically relevant globotriaosyl ceramide receptor binding sites on the Verotoxin 1 B subunit.
Bast DJ; Banerjee L; Clark C; Read RJ; Brunton JL
Mol Microbiol; 1999 Jun; 32(5):953-60. PubMed ID: 10361298
[TBL] [Abstract][Full Text] [Related]
31. Neutralizing activity of bovine colostral antibody against verotoxin derived from enterohemorrhagic Escherichia coli O157:H7 in mice.
Kuribayashi T; Seita T; Fukuyama M; Furuhata K; Honda M; Matsumoto M; Seguchi H; Yamamoto S
J Infect Chemother; 2006 Oct; 12(5):251-6. PubMed ID: 17109087
[TBL] [Abstract][Full Text] [Related]
32. Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2.
Waddell T; Head S; Petric M; Cohen A; Lingwood C
Biochem Biophys Res Commun; 1988 Apr; 152(2):674-9. PubMed ID: 3284526
[TBL] [Abstract][Full Text] [Related]
33. A nontoxigenic form of Shiga toxin 2 suppresses the production of amyloid β by altering the intracellular transport of amyloid precursor protein through its receptor-binding B-subunit.
Sato W; Watanabe-Takahashi M; Hamabata T; Furukawa K; Funamoto S; Nishikawa K
Biochem Biophys Res Commun; 2021 Jun; 557():247-253. PubMed ID: 33894410
[TBL] [Abstract][Full Text] [Related]
34. Monovalent Gb3-/Gb2-derivatives conjugated with a phosphatidyl residue: a novel class of Shiga toxin-neutralizing agent.
Neri P; Tokoro S; Yokoyama S; Miura T; Murata T; Nishida Y; Kajimoto T; Tsujino S; Inazu T; Usui T; Mori H
Biol Pharm Bull; 2007 Sep; 30(9):1697-701. PubMed ID: 17827723
[TBL] [Abstract][Full Text] [Related]
35. The medium is the message: glycosphingolipids and their soluble analogues.
De Rosa M; Park HJ; Mylvaganum M; Binnington B; Lund N; Branch DR; Lingwood CA
Biochim Biophys Acta; 2008 Mar; 1780(3):347-52. PubMed ID: 18022400
[TBL] [Abstract][Full Text] [Related]
36. Differential response of the human renal proximal tubular epithelial cell line HK-2 to Shiga toxin types 1 and 2.
Lentz EK; Leyva-Illades D; Lee MS; Cherla RP; Tesh VL
Infect Immun; 2011 Sep; 79(9):3527-40. PubMed ID: 21708996
[TBL] [Abstract][Full Text] [Related]
37. Effect of globotriaosyl ceramide fatty acid alpha-hydroxylation on the binding by verotoxin 1 and verotoxin 2.
Binnington B; Lingwood D; Nutikka A; Lingwood CA
Neurochem Res; 2002 Aug; 27(7-8):807-13. PubMed ID: 12374217
[TBL] [Abstract][Full Text] [Related]
38. Differences in verotoxin neutralizing activity of therapeutic immunoglobulins and sera from healthy controls.
Bitzan M; Klemt M; Steffens R; Müller-Wiefel DE
Infection; 1993; 21(3):140-5. PubMed ID: 8365810
[TBL] [Abstract][Full Text] [Related]
39. Rapid and specific detection of verotoxin genes in Escherichia coli by the polymerase chain reaction.
Pollard DR; Johnson WM; Lior H; Tyler SD; Rozee KR
J Clin Microbiol; 1990 Mar; 28(3):540-5. PubMed ID: 2182671
[TBL] [Abstract][Full Text] [Related]
40. Isolation and some properties of A and B subunits of Vero toxin 2 and in vitro formation of hybrid toxins between subunits of Vero toxin 1 and Vero toxin 2 from Escherichia coli O157:H7.
Ito H; Yutsudo T; Hirayama T; Takeda Y
Microb Pathog; 1988 Sep; 5(3):189-95. PubMed ID: 3063913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
